Technical Analysis for EXAS - Exact Sciences Corporation

Grade Last Price % Change Price Change
C 53.17 -1.54% -0.83
EXAS closed down 1.54 percent on Friday, May 20, 2022, on 83 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Outside Day Range Expansion 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.54%
Outside Day Range Expansion -1.54%
Wide Bands Range Expansion -1.54%
Shooting Star Candlestick Bearish 2.25%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.25%
MACD Bullish Signal Line Cross Bullish 2.25%
NR7 Range Contraction 2.25%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Exact Sciences Corporation Description

Exact Sciences Corporation, a molecular diagnostics company, focuses on developing diagnostic screening products for the early detection and prevention of colorectal pre-cancer and cancer. The company develops the Cologuard, a non-invasive stool-based DNA colorectal cancer screening test that is designed to detect pre-cancerous lesions or polyps, and each of the four stages of colorectal cancer. Its Cologuard test includes proprietary and patented methods that isolate and analyze the human DNA that are shed into stool every day from the exfoliation of cells that line the colon; and also protein marker to detect blood in the stool, utilizing an antibody-based fecal immunochemical test. The company's stool-based DNA colorectal cancer screening technology also focuses on the inflammatory bowel disease. It has collaboration, license, and purchase agreement with Genzyme Corporation, as well as with Mayo Clinic for developing tests to detect other gastro-intestinal cancers, primarily esophageal and pancreatic cancer. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Cancer Medical Test Pancreatic Cancer Lab Testing Inflammatory Bowel Disease Colorectal Cancer Molecular Diagnostics Polyp Cancer Screening Genzyme Mayo Clinic Diagnostic Gastroenterology

Is EXAS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 133.99
52 Week Low 46.15
Average Volume 2,066,105
200-Day Moving Average 80.98
50-Day Moving Average 62.09
20-Day Moving Average 54.74
10-Day Moving Average 51.43
Average True Range 4.33
RSI 43.82
ADX 29.45
+DI 12.00
-DI 20.57
Chandelier Exit (Long, 3 ATRs) 54.75
Chandelier Exit (Short, 3 ATRs) 59.13
Upper Bollinger Bands 62.85
Lower Bollinger Band 46.63
Percent B (%b) 0.4
BandWidth 29.63
MACD Line -3.29
MACD Signal Line -3.77
MACD Histogram 0.4801
Fundamentals Value
Market Cap 8 Billion
Num Shares 150 Million
EPS -1.76
Price-to-Earnings (P/E) Ratio -30.16
Price-to-Sales 13.72
Price-to-Book 7.93
PEG Ratio -1.07
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 61.14
Resistance 3 (R3) 61.06 58.32 59.81
Resistance 2 (R2) 58.32 56.30 58.36 59.37
Resistance 1 (R1) 55.75 55.04 54.38 55.83 58.92
Pivot Point 53.01 53.01 52.33 53.05 53.01
Support 1 (S1) 50.44 50.98 49.07 50.51 47.42
Support 2 (S2) 47.70 49.73 47.74 46.97
Support 3 (S3) 45.12 47.70 46.53
Support 4 (S4) 45.20